An Intravenous Fish Oil-Based Lipid Emulsion Successfully Treats Intractable Pruritus and Cholestasis in a Patient with Microvillous Inclusion Disease.
作者信息
Anez-Bustillos Lorenzo, Dao Duy T, Potemkin Alexis K, Perez-Atayde Antonio R, Raphael Bram P, Carey Alexandra N, Kamin Daniel S, Thiagarajah Jay R, Crowley McGreggor, Gura Kathleen M, Puder Mark
机构信息
Vascular Biology Program and the Department of Surgery, Boston Children's Hospital, Boston, MA.
Department of Pathology, Boston Children's Hospital, Boston, MA.
出版信息
Hepatology. 2019 Mar;69(3):1353-1356. doi: 10.1002/hep.30311. Epub 2019 Feb 9.
Abstract
摘要
相似文献
1
An Intravenous Fish Oil-Based Lipid Emulsion Successfully Treats Intractable Pruritus and Cholestasis in a Patient with Microvillous Inclusion Disease.一种基于静脉注射鱼油的脂质乳剂成功治疗了一名微绒毛包涵体病患者的顽固性瘙痒和胆汁淤积。
Hepatology. 2019 Mar;69(3):1353-1356. doi: 10.1002/hep.30311. Epub 2019 Feb 9.
2
Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease.使用含 omega-3 脂肪酸的乳剂治疗微绒毛包涵病患者的肠外营养相关性胆汁淤积。
J Pediatr Surg. 2011 Dec;46(12):2376-82. doi: 10.1016/j.jpedsurg.2011.09.061.
3
Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.鱼油静脉用脂肪乳剂单药治疗儿科肠衰竭患者：超越说明书。
Nutr Clin Pract. 2020 Feb;35(1):108-118. doi: 10.1002/ncp.10413. Epub 2019 Sep 24.
4
Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.肠衰竭相关肝病患儿经 6 个月静脉用鱼油治疗后再恢复静脉用大豆油的长期结局。
JPEN J Parenter Enteral Nutr. 2019 Aug;43(6):708-716. doi: 10.1002/jpen.1463. Epub 2018 Nov 8.
5
Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.鱼油乳剂可降低肠衰竭相关肝病患儿的肝损伤和肝移植率：一项多中心综合研究。
J Pediatr. 2021 Mar;230:46-54.e2. doi: 10.1016/j.jpeds.2020.09.068. Epub 2020 Oct 8.
6
Microvillous Inclusion Disease as a Cause of Protracted Diarrhea.微绒毛包涵体病导致迁延性腹泻。
Indian J Pediatr. 2019 Sep;86(9):854-856. doi: 10.1007/s12098-019-02963-y. Epub 2019 May 2.
7
An exclusively based parenteral fish-oil emulsion reverses cholestasis.一种单纯基于肠外的鱼油乳剂可逆转胆汁淤积。
Nutr Hosp. 2014 Oct 25;31(1):514-6. doi: 10.3305/nh.2015.31.1.8284.
8
MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.MYO5B 和胆汁盐输出泵导致微绒毛包涵体病中的胆汁淤积性肝病。
Hepatology. 2014 Jul;60(1):301-10. doi: 10.1002/hep.26974. Epub 2014 May 27.
9
Exclusive Fish Oil Lipid Emulsion Rescue Strategy Improves Cholestasis in Neonates on Partially Fish Oil-Based Lipid Emulsion: A Pilot Study.部分鱼油脂肪乳为基础的脂质乳剂治疗新生儿胆汁淤积的专用鱼油脂质乳剂抢救策略：一项初步研究。
Nutrients. 2023 Jan 18;15(3):509. doi: 10.3390/nu15030509.
10
Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness study.
JPEN J Parenter Enteral Nutr. 2025 Feb;49(2):180-188. doi: 10.1002/jpen.2713. Epub 2024 Dec 21.
引用本文的文献
1
Microvillus inclusion disease: a short review of literature.微绒毛包涵体病：文献综述
Gastroenterol Hepatol Bed Bench. 2025;18(1):6-9. doi: 10.22037/ghfbb.v18i1.3069.
2
Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19.雾化 ω-3 脂肪酸吸入减轻脂多糖诱导的大鼠急性肺炎症：对 COPD 和 COVID-19 治疗的启示。
Prostaglandins Leukot Essent Fatty Acids. 2022 Apr;179:102426. doi: 10.1016/j.plefa.2022.102426. Epub 2022 Mar 30.
3
Pharmacological and Parenteral Nutrition-Based Interventions in Microvillus Inclusion Disease.基于药理和肠外营养的微绒毛包涵体病干预措施
J Clin Med. 2020 Dec 23;10(1):22. doi: 10.3390/jcm10010022.
4
Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.肌球蛋白5B突变在肝脏和肠道中的不同作用决定了低γ-谷氨酰转移酶胆汁淤积症的临床表现。
Hepatology. 2020 Oct;72(4):1461-1468. doi: 10.1002/hep.31430.
5
A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.一种由 MYO5B 突变引起的基因型特异性肝内胆汁淤积的分子机制。
Hepatology. 2020 Jul;72(1):213-229. doi: 10.1002/hep.31002. Epub 2020 Apr 23.
本文引用的文献
1
Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.肌球蛋白VB缺陷与一系列先前未被诊断出的低γ-谷氨酰转移酶胆汁淤积症有关。
Hepatology. 2017 May;65(5):1655-1669. doi: 10.1002/hep.29020. Epub 2017 Mar 23.
2
MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.MYO5B 突变导致儿童胆汁淤积症伴正常血清 γ-谷氨酰转移酶活性，而无微绒毛包涵体病。
Hepatology. 2017 Jan;65(1):164-173. doi: 10.1002/hep.28779. Epub 2016 Oct 5.
3
MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.MYO5B 和胆汁盐输出泵导致微绒毛包涵体病中的胆汁淤积性肝病。
Hepatology. 2014 Jul;60(1):301-10. doi: 10.1002/hep.26974. Epub 2014 May 27.
4
Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites.膳食补充鱼油（n-3）和琉璃苣油（n-6）多不饱和脂肪酸的乙酯浓缩物可诱导表皮产生局部假定的抗炎代谢产物。
J Invest Dermatol. 1991 Jan;96(1):98-103. doi: 10.1111/1523-1747.ep12515911.
Zotero 插件